4'-Bromo-4-methylaminorex (4B-MAR, 4'-Br-4-MAR) is a designer drug from the substituted aminorex family, first definitively identified in Austria in January 2022. Its pharmacological activity has not been reported, but it is believed to have stimulant effects.
See also
- 2C-B-aminorex
- 2F-MAR
- 4C-MAR
- 4,4'-DMAR
- 4'-Fluoro-4-methylaminorex
- 4-Methylaminorex
- MDMAR
- 3-Bromomethylphenidate
- 4-Bromoamphetamine
- 4-Bromomethcathinone
- RTI-51
References
